Axsome Therapeutics Inc.

Last updated September 27, 2026

Organization details

Legal name
Axsome Therapeutics Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
New York
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
December
Ticker symbol
AXSM
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001579428
EIN
45-4241907

Board of directors

Chief executives

Herriot Tabuteau · CHIEF EXECUTIVE OFFICER
Dates unknown

Director election results

Annual meeting of June 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 3 other boards. 3 are in the same sector.

Network of Axsome Therapeutics Inc.'s board connections Assembly Biosciences Inc. Assembly Biosciences I... Liquidia Corporation Liquidia Corporation Zymeworks Inc. Zymeworks Inc. Roger Jeffs Roger Jeffs Susan Mahony Susan Mahony Axsome Therapeutics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$112,513,715
30 sales by 8 insiders
Date Insider Transaction Shares Price Value
Sep 3, 2026 Jacobson Mark L. Officer (Chief Operating Officer) Option exercise +10,000 $12.95 $129,500
Sep 3, 2026 Jacobson Mark L. Officer (Chief Operating Officer) Open-market sale −10,000 $208.65 $2,086,500
Aug 6, 2026 Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner Option exercise +4,660 $4.95 $23,067
Aug 6, 2026 Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner Open-market sale −4,660 $213.95 $997,007
Aug 5, 2026 Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner Option exercise +45,004 $4.95 $222,770
Aug 5, 2026 Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner Open-market sale −45,004 $212.01 $9,541,298
Jul 1, 2026 Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner Option exercise +49,666 $4.95 $245,847
Jul 1, 2026 Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner Open-market sale −49,666 $240.25 $11,932,257
Jun 11, 2026 Roger Jeffs Director Open-market sale −286 $249.12 $71,248
Jun 10, 2026 Roger Jeffs Director Open-market sale −286 $246.18 $70,407
Jun 10, 2026 Mark Coleman Director Open-market sale −643 $249.00 $160,107
Jun 10, 2026 Susan Mahony Director Open-market sale −300 $246.18 $73,854
Jun 9, 2026 Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner Option exercise +49,670 $4.95 $245,867
Jun 9, 2026 Pizzie Nick Officer (Chief Financial Officer) Option exercise +33,000 $3.50 $115,500
Jun 9, 2026 Susan Mahony Director Open-market sale −300 $237.21 $71,163

Organizations in the same sector, closest in location and size first.

Questions about Axsome Therapeutics Inc.

Who is the CEO of Axsome Therapeutics Inc.?

Herriot Tabuteau is Axsome Therapeutics Inc.'s CHIEF EXECUTIVE OFFICER.

How many directors are on Axsome Therapeutics Inc.'s board?

Axsome Therapeutics Inc.'s board has 5 directors: Herriot Tabuteau, Mark Coleman, Mark E. Saad, Roger Jeffs and Susan Mahony.

Are Axsome Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Axsome Therapeutics Inc. insiders made no open-market purchases and sold $112.5 million of shares in 30 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="axsome-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.